Here are four things to know:
1. Nobilis will delist its shares at the close of the markets on Dec. 30, 2016.
2. The TSX delisting will not impact Nobilis’ listing on the New York Stock Exchange.
3. On the NYSE MKT, Nobilis common shares will hold the symbol “HLTH.”
4. Canadian shareholders can trade their Nobilis shares on the NYSE MKT through their brokers that have U.S. registered broker-dealer affiliates.
“After careful consideration, the directors of the company can no longer justify the expenses and administrative efforts, among other factors, associated with maintaining a dual listing,” said Donald Kramer, MD, board chairman, Nobilis. “Delisting from the TSX will create a central marketplace for Nobilis shares and we believe that harmonizing our U.S.-based operational focus with a single U.S.-based trading platform will enhance the company’s long term liquidity, analyst coverage and access to U.S. financing. We believe this is a prudent move for shareholders.”
More articles on surgery centers:
UMBD Orthopaedics & Sports Medicine expands: 3 things to know
What physicians and patients want changed in the ACA — and what they want to stay the same: 7 trends
Nebraska Medicine to hold ribbon-cutting ceremony for $71M surgery center — 5 notes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.